T. Rowe Price Investment Management’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-547,667	Closed	-$4.8M	–	546
2022 Q3	$4.8M	Buy	+547,667	New	+$4.8M	﹤0.01%	526